Welcome to the website of EFIS


EFIS on Tour


EFIS is pleased to announce the eighth EFIS on Tour Symposium, to be held in Istanbul with the support of the Turkish Society of Immunology (TSI), this coming Friday, September 27, 2019. Download the full-day program - featuring the EFIS Board, TSI representatives and special guest speakers Andreas Diefenbach and Antonio Lanzavecchia - here.

ACTERIA Prizes awarded by EFIS


The FONDATION ACTERIA and EFIS are delighted to announce new rules and the imminent call for applications for the ACTERIA Prizes awarded by EFIS!

Together with the FONDATION ACTERIA - ACTing on European Research in Immunology and Allergology - EFIS will be awarding from 2020 onward ACTERIA Doctoral Thesis and Early Career Research Prizes in immunology and allergology on a yearly basis. Download the announcement here.

EFIS-EJI Travel Grants for IUIS 2019!!!


Thanks to the continuing collaboration of its Official Journal, the European Journal of Immunology and to the generous contribution of the Fondation ACTERIA - EFIS is pleased to announce the shorlisted recipients of EFIS-EJI and EFIS-ACTERIA Travel Grants for the 17th International Congress of Immunology - IUIS 2019 - to be held October 19-23, 2019, in Beijing:
  • Yunhao Zhai - Centre d’Immunologie de Marseille Luminy, Aix Marseille University, France (Societe Francaise d'Immunologie - SFI)
  • Na Li - Leiden University Medical Center, Leiden, The Netherlands (Nederlandse Vereniging voor Immunologie - NVvI)
  • Valentina Pucino - University of Birmingham, United Kingdom (British Society for Immunology - BSI)
  • Irene Mattiola - Charité - Universitätsmedizin Berlin, Germany (Società Italiana di Immunologia, Immunologia Clinica e Allergologia - SIICA)
  • Gennaro Prota - University of Oxford, United Kingdom (British Society for Immunology - BSI)
  • Ana Rita Faria dos Santos - i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal (Sociedade Portuguesa de Imunologia - SPI)
  • Ramy Elsaid - Institut Pasteur de Paris, France (Societe Francaise d'Immunologie - SFI)
  • Carla Guenther - University of Helsinki, Finland (Suomen Immunologiayhdistys Ry - SIY; Scandinavian Society for Immunology - SSI)
  • Andrea Ponzetta - Istituto Clinico Humanitas, Rozzano, Italy (Società Italiana di Immunologia, Immunologia Clinica e Allergologia - SIICA)
  • Natasja Wulff Pedersen - Technical University of Denmark, Lyngby, Denmark (Dansk Immunologisk Selskab - DIS; Scandinavian Society for Immunology - SSI)
  • Kamar-Sulu Atretkhany - Engelhardt Insitute of Molecular Biology, Moscow, Russia (Russian Society for Immunology - RSI)
  • Lucie Loyal - Berlin-Brandenburg Center for Regenerative Therapies/Charité, Berlin, Germany (Deutsche Gesellschaft für Immunologie - DGfI)

EFIS Task Forces soon to launch!


Building on consensus reached during the first EFIS Strategic Retreat in Berlin this past March, three EFIS Task Forces, composed of representatives nominated by National Societies, are now taking shape and will soon kick off. Read more here.

European Journal of Immunology 2018 IF = 4.695!


EFIS is excited to share that the Impact Factor of European Journal of Immunology (EJI) has increased to 4.695. A special thanks to EFIS Societies and their members for your essential contributions in reaching this milestone: your research is advancing the field and EFIS hopes you’ll continue to publish with EJI in the future. Visit here to get started!

The HCDM-HLDA invites submissions of mAbs for CD Nomenclature Assignment

The Human Cell Differentiation Molecules-Human Leukocyte Differentiation Antigen Workshop is inviting the submission of newly generated monoclonal antibodies against G protein-coupled receptors for validation and CD nomenclature assignment. More details are available here or on the HCDM homepage.